Polymer composite nanomaterial encapsulation system
The polymer synthesis technology encapsulates quantum dots or superparamagnetic iron oxide nanoparticles and binds antibodies to solve the problems of polymerization, low photochemical stability and insufficient specific binding ability in nanocomposite manufacturing, and achieves efficient and specific nanocomposite manufacturing.
Patent Information
- Application Number
- CN202380064082.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-09-13
- Filing Date
- 2023-08-18
- Publication Date
- 2025-05-02
AI Technical Summary
The prior art has problems such as conjugation, low photochemical stability, inconsistent particle size, insufficient brightness and lack of specificity for cell targets when manufacturing nanocomposites.
Using polymer synthesis technology, quantum dots (QDs) or superparamagnetic iron oxide nanoparticles (SPION) are encapsulated by polystyrene-b-polyethylene glycolamine (PS-b-PEG-NH2), binding to antibodies or antibody fragments to form nanocomplexes with specific binding capabilities.
Large-scale manufacturing of nanocomplexes with consistent particle size and high brightness is achieved, which improves the specific binding ability to cell targets, and simplifies the purification of nanocomplexes and the binding process of cell targets.